paclitaxel has been researched along with Osteolysis in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chung, YS; Kang, HC; Lee, T | 1 |
Hauff, P; Hoffmann, J; Käkönen, SM; Klar, U; Stepina, E; Strube, A | 1 |
Ang, ES; Chim, SM; Feng, HT; Pavlos, NJ; Scaife, RM; Steer, JH; Xu, J; Zheng, MH | 1 |
Feenstra, J; Stricker, BH; Vermeer, RJ | 1 |
4 other study(ies) available for paclitaxel and Osteolysis
Article | Year |
---|---|
Comparative Effects of Ibandronate and Paclitaxel on Immunocompetent Bone Metastasis Model.
Topics: Amino Acids; Animals; Biomechanical Phenomena; Bone Density; Bone Neoplasms; Bone Resorption; Diphosphonates; Ibandronic Acid; Immunocompetence; Male; Neoplasm Metastasis; Osteolysis; Paclitaxel; Rats; Rats, Sprague-Dawley | 2015 |
Sagopilone inhibits breast cancer bone metastasis and bone destruction due to simultaneous inhibition of both tumor growth and bone resorption.
Topics: Acid Phosphatase; Animals; Antineoplastic Agents, Phytogenic; Benzothiazoles; Bone and Bones; Bone Neoplasms; Bone Resorption; Cachexia; Cell Line, Tumor; Dose-Response Relationship, Drug; Epothilones; Female; Humans; Isoenzymes; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Osteoclasts; Osteolysis; Paclitaxel; Tartrate-Resistant Acid Phosphatase; Tumor Burden; Xenograft Model Antitumor Assays | 2009 |
Paclitaxel inhibits osteoclast formation and bone resorption via influencing mitotic cell cycle arrest and RANKL-induced activation of NF-κB and ERK.
Topics: Animals; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Bone Resorption; Cell Line; Cytoskeleton; Extracellular Signal-Regulated MAP Kinases; Giant Cell Tumor of Bone; Humans; M Phase Cell Cycle Checkpoints; Mice; Mice, Inbred C57BL; Mitosis; NF-kappa B; Osteoclasts; Osteolysis; Paclitaxel; RANK Ligand | 2012 |
Mesenteric venous thrombosis attributed to docetaxel.
Topics: Antineoplastic Agents, Phytogenic; Bone Neoplasms; Breast Neoplasms; Docetaxel; Female; Humans; Lung Neoplasms; Mesenteric Vascular Occlusion; Mesenteric Veins; Middle Aged; Osteolysis; Paclitaxel; Sternum; Taxoids; Venous Thrombosis | 2000 |